Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding
ABSTRACT As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread around the world, there is an urgent need for new assay formats to characterize the humoral response to infection. Here, we present an efficient, competitive serological assay that can simultaneously determi...
Guardado en:
Autores principales: | James R. Byrnes, Xin X. Zhou, Irene Lui, Susanna K. Elledge, Jeff E. Glasgow, Shion A. Lim, Rita P. Loudermilk, Charles Y. Chiu, Taia T. Wang, Michael R. Wilson, Kevin K. Leung, James A. Wells |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/37d9f89d63ed4f75ab01f6157803f4a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Measurement of serum ACE status may potentially improve the diagnosis of SARS-CoV-2 infection
por: Gcinokwakhe D Ngcobo
Publicado: (2021) -
The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
por: O. K. Vikulova, et al.
Publicado: (2020) -
The Role of the ACE2/MasR Axis in Ischemic Stroke: New Insights for Therapy
por: Mansoureh Barzegar, et al.
Publicado: (2021) -
Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Oghenemega Okoloko, et al.
Publicado: (2021) -
2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications
por: Luigi Cappannoli, et al.
Publicado: (2020)